NCT04928261 Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE4
NCT04928014 Validation of a Tear-based Screening Assay for Breast Cancer Status ENROLLING_BY_INVITATION Phase N/A
NCT04927481 A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced HER2 Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT04926766 Super Hypofractionated Irradiation for Whole Breast Treatment Status ACTIVE_NOT_RECRUITING Phase NA
NCT04925856 Immunomonitoring of Breast Cancer Patients During Systemic Treatment Status RECRUITING Phase NA
NCT04924010 Effect of Perioperative CBT on Chronic Persistent Postsurgical Pain Among Breast Cancer Patients Status COMPLETED Phase NA
NCT04922008 Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D) Status NOT_YET_RECRUITING Phase PHASE2
NCT04921137 Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer Status RECRUITING Phase PHASE4
NCT04920656 Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer Status COMPLETED Phase N/A
NCT04917900 Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT04917640 Registry for Accelerated Partial Breast Irradiation With (SBRT) or (IMRT) Status WITHDRAWN Phase N/A
NCT04914780 The Effect of Training Given by Mobile Application to Women Undergoing Breast Surgery Status COMPLETED Phase NA
NCT04913532 Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer Status COMPLETED Phase NA
NCT04913337 Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT04909554 MRI-based Approaches for Multi-parametric Model to Early Predict Pathological Complete Response to Neoadjuvant Therapy in Breast Cancer Status COMPLETED Phase N/A